Kenneth Rock to Immunotherapy
This is a "connection" page, showing publications Kenneth Rock has written about Immunotherapy.
Connection Strength
1.234
-
Sari G, Dhatchinamoorthy K, Orellano-Ariza L, Ferreira LM, Brehm MA, Rock K. IRF2 loss is associated with reduced MHC I pathway transcripts in subsets of most human cancers and causes resistance to checkpoint immunotherapy in human and mouse melanomas. J Exp Clin Cancer Res. 2024 Oct 02; 43(1):276.
Score: 0.785
-
Rock KL, Reits E, Neefjes J. Present Yourself! By MHC Class I and MHC Class II Molecules. Trends Immunol. 2016 11; 37(11):724-737.
Score: 0.449